|
US2466420A
(en)
|
1947-11-26 |
1949-04-05 |
Eastman Kodak Co |
Ketene condensation products with aldehydes
|
|
US3226394A
(en)
|
1964-06-16 |
1965-12-28 |
Shulton Inc |
Pyridylethylated anthranilamides and derivatives thereof
|
|
CH504416A
(de)
|
1966-12-05 |
1971-03-15 |
Ciba Geigy Ag |
Verfahren zur Herstellung von aromatischen Sulfamoylverbindungen
|
|
US4551540A
(en)
|
1983-01-17 |
1985-11-05 |
Borg-Warner Chemicals, Inc. |
Substituted 2,5-dimethylpyrroles
|
|
US4574765A
(en)
*
|
1984-11-30 |
1986-03-11 |
Donald E. Goorhouse |
Supplemental air injection method and devices for carburetors of internal combustion engines
|
|
US5190541A
(en)
|
1990-10-17 |
1993-03-02 |
Boston Scientific Corporation |
Surgical instrument and method
|
|
EP1306095A3
(en)
|
1992-03-05 |
2003-06-25 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
|
US5474765A
(en)
|
1992-03-23 |
1995-12-12 |
Ut Sw Medical Ctr At Dallas |
Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells
|
|
US5686472A
(en)
|
1992-10-29 |
1997-11-11 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US5593992A
(en)
|
1993-07-16 |
1997-01-14 |
Smithkline Beecham Corporation |
Compounds
|
|
WO1996011932A1
(en)
|
1994-10-14 |
1996-04-25 |
Smithkline Beecham Plc |
2-(imidazol-4-yl)carbapeneme derivatives, intermediates thereof and use as antibacterials
|
|
DE69623455T2
(de)
|
1995-04-19 |
2003-01-16 |
Schneider (Usa) Inc., Plymouth |
Beschichteter dilatator zur abgabe eines arzneistoffs
|
|
US6117432A
(en)
|
1995-04-20 |
2000-09-12 |
Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) |
Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
|
|
TW349948B
(en)
|
1995-10-31 |
1999-01-11 |
Janssen Pharmaceutica Nv |
Farnesyl transferase inhibiting 2-quinolone derivatives
|
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
DE69620445T2
(de)
|
1995-12-08 |
2002-12-12 |
Janssen Pharmaceutica N.V., Beerse |
(imidazol-5-yl)methyl-2-chinolinoderivate als farnesyl protein transferase inhibitoren
|
|
US5874442A
(en)
|
1995-12-22 |
1999-02-23 |
Schering-Plough Corporation |
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
|
|
US6011029A
(en)
|
1996-02-26 |
2000-01-04 |
Bristol-Myers Squibb Company |
Inhibitors of farnesyl protein transferase
|
|
US5702390A
(en)
|
1996-03-12 |
1997-12-30 |
Ethicon Endo-Surgery, Inc. |
Bioplar cutting and coagulation instrument
|
|
AU711936B2
(en)
|
1996-08-09 |
1999-10-28 |
Banyu Pharmaceutical Co., Ltd. |
Stereoselective deoxygenation reaction
|
|
UA59384C2
(uk)
|
1996-12-20 |
2003-09-15 |
Пфайзер, Інк. |
Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
|
|
ATE252104T1
(de)
|
1996-12-20 |
2003-11-15 |
Tovarischestvo S Ogranichennoi |
Verfahren und gerät zur herstellung von 1ss, 10ss-epoxy-13-dimethylamino-guaia-3(4)-en-6,12- lid- hydrochlorid
|
|
TW591030B
(en)
|
1997-03-10 |
2004-06-11 |
Janssen Pharmaceutica Nv |
Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
|
|
RU2205831C2
(ru)
|
1997-04-25 |
2003-06-10 |
Янссен Фармацевтика Н.В. |
Хиназолиноны, ингибирующие фарнезилтрансферазу
|
|
TW491872B
(en)
|
1997-05-27 |
2002-06-21 |
Ciba Sc Holding Ag |
Block oligomers containing l-hydrocarbyloxy-2,2,6,6-tetramethyl-4- piperidyl groups as stabilizers for lower polyolefin
|
|
US6100254A
(en)
|
1997-10-10 |
2000-08-08 |
Board Of Regents, The University Of Texas System |
Inhibitors of protein tyrosine kinases
|
|
JP4022044B2
(ja)
|
1998-03-05 |
2007-12-12 |
フォーミュラ ワン アドミニストレイション リミテッド |
データ通信システム
|
|
US6303654B1
(en)
|
1998-03-12 |
2001-10-16 |
Wisconsin Alumni Research Foundation |
Acyclic monoterpenoid derivatives
|
|
AU5086499A
(en)
|
1998-07-01 |
2000-01-24 |
Merck & Co., Inc. |
Process for making farnesyl-protein transferase inhibitors
|
|
AU747427B2
(en)
|
1998-07-10 |
2002-05-16 |
Merck & Co., Inc. |
Novel angiogenesis inhibitors
|
|
TR200101343T2
(tr)
|
1998-08-27 |
2001-09-21 |
Pfizer Products Inc. |
Kansere karşı kullanılan maddeler olarak alkinil-ikame edilmiş kinolin-2-on türevleri
|
|
DE69923849T2
(de)
|
1998-08-27 |
2006-01-12 |
Pfizer Products Inc., Groton |
Quinolin-2-on-derivate verwendbar als antikrebsmittel
|
|
GB9824579D0
(en)
|
1998-11-10 |
1999-01-06 |
Novartis Ag |
Organic compounds
|
|
DK1140935T3
(da)
|
1998-12-23 |
2003-09-01 |
Janssen Pharmaceutica Nv |
1,2-anellerede quinolinderivater
|
|
DK1140938T3
(da)
|
1999-01-11 |
2003-12-22 |
Univ Princeton |
Højaffinitetsinhibitorer for målvalidering og anvendelser heraf
|
|
US7125875B2
(en)
|
1999-04-15 |
2006-10-24 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
|
PL215901B1
(pl)
|
1999-04-15 |
2014-02-28 |
Bristol Myers Squibb Co |
Cykliczny inhibitor bialkowych kinaz tyrozynowych, jego zastosowanie oraz kompozycja farmaceutyczna zawierajaca taki zwiazek
|
|
EP1179541B1
(en)
|
1999-04-28 |
2004-06-16 |
Board Of Regents, The University Of Texas System |
Compositions and methods for cancer treatment by selectively inhibiting VEGF
|
|
US6346625B1
(en)
|
1999-06-23 |
2002-02-12 |
Astrazeneca Ab |
Protein kinase inhibitors
|
|
DE19962924A1
(de)
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituierte Oxazolidinone und ihre Verwendung
|
|
CA2394727A1
(en)
|
1999-12-28 |
2001-07-05 |
Pharmacopeia, Inc. |
Pyrimidine and triazine kinase inhibitors
|
|
FR2803592A1
(fr)
|
2000-01-06 |
2001-07-13 |
Aventis Cropscience Sa |
Nouveaux derives de l'acide 3-hydroxypicolinique, leur procede de preparation et compositions fongicides les contenant.
|
|
US6558385B1
(en)
|
2000-09-22 |
2003-05-06 |
Tissuelink Medical, Inc. |
Fluid-assisted medical device
|
|
US6692491B1
(en)
|
2000-03-24 |
2004-02-17 |
Scimed Life Systems, Inc. |
Surgical methods and apparatus for positioning a diagnostic or therapeutic element around one or more pulmonary veins or other body structures
|
|
US6776796B2
(en)
|
2000-05-12 |
2004-08-17 |
Cordis Corportation |
Antiinflammatory drug and delivery device
|
|
AU2002226877B2
(en)
|
2000-10-17 |
2006-01-12 |
Merck & Co., Inc. |
Orally active salts with tyrosine kinase activity
|
|
US7105682B2
(en)
|
2001-01-12 |
2006-09-12 |
Amgen Inc. |
Substituted amine derivatives and methods of use
|
|
AR035885A1
(es)
|
2001-05-14 |
2004-07-21 |
Novartis Ag |
Derivados de 4-amino-5-fenil-7-ciclobutilpirrolo (2,3-d)pirimidina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la preparacion de una composicion farmaceutica
|
|
US7101884B2
(en)
|
2001-09-14 |
2006-09-05 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
WO2003024931A1
(en)
|
2001-09-14 |
2003-03-27 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
TWI259081B
(en)
|
2001-10-26 |
2006-08-01 |
Sugen Inc |
Treatment of acute myeloid leukemia with indolinone compounds
|
|
ES2269793T3
(es)
|
2001-10-30 |
2007-04-01 |
Novartis Ag |
Derivados de estaurospina como inhibidores de la actividad de tirosina quinasa receptora flt3.
|
|
ATE302771T1
(de)
|
2001-12-27 |
2005-09-15 |
Theravance Inc |
Indolinon-derivative als protein-kinasehemmer
|
|
DE60317198T2
(de)
|
2002-05-23 |
2008-12-04 |
Cytopia Research Pty. Ltd., Richmond |
Proteinkinaseinhibitoren
|
|
TW200406374A
(en)
|
2002-05-29 |
2004-05-01 |
Novartis Ag |
Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
|
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
|
GB0215676D0
(en)
|
2002-07-05 |
2002-08-14 |
Novartis Ag |
Organic compounds
|
|
MXPA05001804A
(es)
|
2002-08-14 |
2005-05-27 |
Vertex Pharma |
Inhibidores de proteinas cinasas y usos de los mismos.
|
|
CA2496164C
(en)
|
2002-08-23 |
2010-11-09 |
Chiron Corporation |
Benzimidazole quinolinones and uses thereof
|
|
AU2003258491A1
(en)
|
2002-09-05 |
2004-03-29 |
Neurosearch A/S |
Amide derivatives and their use as chloride channel blockers
|
|
KR20120032574A
(ko)
|
2002-10-03 |
2012-04-05 |
탈자진 인코포레이티드 |
혈관항상성 유지제 및 그의 사용 방법
|
|
AU2003280599A1
(en)
|
2002-10-29 |
2004-05-25 |
Kirin Beer Kabushiki Kaisha |
QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF Flt3 AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
|
|
AU2003290699B2
(en)
|
2002-11-13 |
2009-08-27 |
Novartis Vaccines And Diagnostics, Inc. |
Methods of treating cancer and related methods
|
|
CL2003002353A1
(es)
|
2002-11-15 |
2005-02-04 |
Vertex Pharma |
Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic
|
|
US7226919B2
(en)
|
2002-12-18 |
2007-06-05 |
Vertex Pharmaceuticals Inc. |
Compositions useful as inhibitors of protein kinases
|
|
MXPA05010945A
(es)
|
2003-04-09 |
2005-11-25 |
Japan Tobacco Inc |
Compuesto pentaciclico heteroaromatico y uso medicinal del mismo.
|
|
US7429603B2
(en)
*
|
2003-04-25 |
2008-09-30 |
3-Dimensional Pharmaceuticals, Inc. |
C-fms kinase inhibitors
|
|
US7427683B2
(en)
*
|
2003-04-25 |
2008-09-23 |
Ortho-Mcneil Pharmaceutical, Inc. |
c-fms kinase inhibitors
|
|
US20050113566A1
(en)
*
|
2003-04-25 |
2005-05-26 |
Player Mark R. |
Inhibitors of C-FMS kinase
|
|
US7790724B2
(en)
|
2003-04-25 |
2010-09-07 |
Janssen Pharmaceutica N.V. |
c-fms kinase inhibitors
|
|
BRPI0413013A
(pt)
|
2003-07-28 |
2006-10-03 |
Smithkline Beecham Corp |
composto, seus sais, solvatos, e derivados farmaceuticamente funcionais, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou distúrbios, e de doenças
|
|
EP1684750B1
(en)
|
2003-10-23 |
2010-04-28 |
AB Science |
2-aminoaryloxazole compounds as tyrosine kinase inhibitors
|
|
GB0326601D0
(en)
|
2003-11-14 |
2003-12-17 |
Novartis Ag |
Organic compounds
|
|
CA2554925A1
(en)
|
2004-01-30 |
2005-08-11 |
Ab Science |
2-(3-substituted-aryl)amino-4-aryl-thiazoles as tyrosine kinase inhibitors
|
|
US7662837B2
(en)
*
|
2004-10-22 |
2010-02-16 |
Janssen Pharmaceutica N.V. |
Inhibitors of c-fms kinase
|
|
WO2006047504A1
(en)
|
2004-10-22 |
2006-05-04 |
Janssen Pharmaceutica, N.V. |
Aromatic amides as inhibitors of c-fms kinase
|
|
ES2611604T3
(es)
*
|
2004-10-22 |
2017-05-09 |
Janssen Pharmaceutica Nv |
Inhibidores de la c fms quinasa
|
|
US7645755B2
(en)
|
2004-10-22 |
2010-01-12 |
Janssen Pharmaceutical N.V. |
Inhibitors of c-fms kinase
|
|
US20060281755A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators
|
|
US20060281788A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor
|
|
US20060281769A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using thienopyrimidine and thienopyridine kinase modulators
|
|
US20060281700A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators
|
|
US20060281771A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using aminoquinoline and aminoquinazoline kinase modulators
|
|
KR101443651B1
(ko)
|
2005-10-18 |
2014-09-23 |
얀센 파마슈티카 엔.브이. |
Ｆｌｔ-3 키나제의 억제 방법
|
|
NZ572073A
(en)
|
2006-04-20 |
2011-09-30 |
Janssen Pharmaceutica Nv |
Heterocyclic compounds as inhibitors of c-fms kinase
|
|
EP2021329B1
(en)
|
2006-04-20 |
2016-04-13 |
Janssen Pharmaceutica N.V. |
Inhibitors of c-fms kinase
|
|
US8697716B2
(en)
|
2006-04-20 |
2014-04-15 |
Janssen Pharmaceutica Nv |
Method of inhibiting C-KIT kinase
|
|
BRPI0710548B8
(pt)
|
2006-04-20 |
2021-05-25 |
Janssen Pharmaceutica Nv |
inibidores de c-fms cinase, composição farmacêutica e forma de dosagem farmacêutica
|
|
JO3240B1
(ar)
|
2007-10-17 |
2018-03-08 |
Janssen Pharmaceutica Nv |
c-fms مثبطات كيناز
|
|
CA2704231A1
(en)
|
2007-10-31 |
2009-05-07 |
Janssen Pharmaceutica N.V. |
Biomarker for assessing response to fms treatment
|